The Stanford Securities Class Action Clearinghouse (SCAC) is currently under construction and is temporarily unavailable as it undergoes updates and improvements. The Clearinghouse is expected to return as part of the Stanford Rock Center for Corporate Governance in Winter 2026.
During this period, updates and new filings will not be available.
Aimmune Investors' $27.5M Deal in Nestle Suit Gets Final OK
Emilie Ruscoe, Law360 - Securities, July 21, 2025
Excerpt:
Investors in biopharmaceutical company Aimmune Therapeutics Inc. have gotten final approval for their $27.5 million deal resolving claims the company was falsely undervalued before its merger with Nestlé Health Science SA. [...]
